Board recommended a final dividend of Rs 7 per share for FY26, bringing total dividend to Rs 9.33 post-bonus adjustment.
Appointed Price Waterhouse as new statutory auditors for a five-year term, replacing M S K A & Associates.
Re-appointed Rahul Guha as MD & CEO for five years and appointed two new non-executive directors.
Approved investment of up to Rs 5.5 crore in wholly-owned subsidiary Think Health Diagnostics.